Thompson A - Search Results

1

The SF-36 in multiple sclerosis: why basic assumptions must be tested.

Hobart J, Freeman J, Lamping D, Fitzpatrick R, Thompson A. Hobart J, et al. Among authors: thompson a. J Neurol Neurosurg Psychiatry. 2001 Sep;71(3):363-70. doi: 10.1136/jnnp.71.3.363. J Neurol Neurosurg Psychiatry. 2001. PMID: 11511712 Free PMC article.

2

Kurtzke scales revisited: the application of psychometric methods to clinical intuition.

Hobart J, Freeman J, Thompson A. Hobart J, et al. Among authors: thompson a. Brain. 2000 May;123 ( Pt 5):1027-40. doi: 10.1093/brain/123.5.1027. Brain. 2000. PMID: 10775547

3

The Multiple Sclerosis Impact Scale (MSIS-29): a new patient-based outcome measure.

Hobart J, Lamping D, Fitzpatrick R, Riazi A, Thompson A. Hobart J, et al. Among authors: thompson a. Brain. 2001 May;124(Pt 5):962-73. doi: 10.1093/brain/124.5.962. Brain. 2001. PMID: 11335698

4

Outcome measures for multiple sclerosis clinical trials: relative measurement precision of the Expanded Disability Status Scale and Multiple Sclerosis Functional Composite.

Hobart J, Kalkers N, Barkhof F, Uitdehaag B, Polman C, Thompson A. Hobart J, et al. Among authors: thompson a. Mult Scler. 2004 Feb;10(1):41-6. doi: 10.1191/1352458504ms983oa. Mult Scler. 2004. PMID: 14760951

5

A comparison of two neurologic scoring instruments for multiple sclerosis.

Hobart J, Thompson A. Hobart J, et al. Among authors: thompson a. J Neurol. 1997 Jan;244(1):60-1. J Neurol. 1997. PMID: 9007749 No abstract available.

6

Using the Short Form-36 with multiple sclerosis patients in five countries: a cross-cultural comparison.

Pfennings L, Cohen L, Miller D, Gerbaud L, Vleugels L, Freeman J, Vernay D, Biolay S, Ketelaer P, Thompson A, Polman C, van der Ploeg H. Pfennings L, et al. Among authors: thompson a. Psychol Rep. 1999 Aug;85(1):19-31. doi: 10.2466/pr0.1999.85.1.19. Psychol Rep. 1999. PMID: 10575971

7

Long-term clinical relevance of criteria for designating multiple sclerosis as benign after 10 years of disease.

Costelloe L, Thompson A, Walsh C, Tubridy N, Hutchinson M. Costelloe L, et al. Among authors: thompson a. J Neurol Neurosurg Psychiatry. 2008 Nov;79(11):1245-8. doi: 10.1136/jnnp.2008.143586. Epub 2008 May 13. J Neurol Neurosurg Psychiatry. 2008. PMID: 18477712

8

Evaluating the role of botulinum toxin in the management of focal hypertonia in adults.

Richardson D, Sheean G, Werring D, Desai M, Edwards S, Greenwood R, Thompson A. Richardson D, et al. Among authors: thompson a. J Neurol Neurosurg Psychiatry. 2000 Oct;69(4):499-506. doi: 10.1136/jnnp.69.4.499. J Neurol Neurosurg Psychiatry. 2000. PMID: 10990511 Free PMC article. Clinical Trial.

9

Expression of beta2 adrenoreceptors on peripheral blood mononuclear cells in patients with primary and secondary progressive multiple sclerosis: a longitudinal six month study.

Zoukos Y, Thomaides TN, Kidd D, Cuzner ML, Thompson A. Zoukos Y, et al. Among authors: thompson a. J Neurol Neurosurg Psychiatry. 2003 Feb;74(2):197-202. doi: 10.1136/jnnp.74.2.197. J Neurol Neurosurg Psychiatry. 2003. PMID: 12531948 Free PMC article.

10

T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis.

Bodini B, Battaglini M, De Stefano N, Khaleeli Z, Barkhof F, Chard D, Filippi M, Montalban X, Polman C, Rovaris M, Rovira A, Samson R, Miller D, Thompson A, Ciccarelli O. Bodini B, et al. Among authors: thompson a. J Neurol Neurosurg Psychiatry. 2011 Jan;82(1):72-7. doi: 10.1136/jnnp.2009.201574. Epub 2010 Jul 13. J Neurol Neurosurg Psychiatry. 2011. PMID: 20627965 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,995 results

Search Page

Filters